UBS Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.65M Buy
1,298,173
+1,146,741
+757% +$4.56M ﹤0.01% 4151
2025
Q4
$532K Sell
151,432
-381,560
-72% -$1.31M ﹤0.01% 6043
2025
Q3
$1.74M Sell
532,992
-303,516
-36% -$956K ﹤0.01% 5090
2025
Q2
$2.05M Buy
836,508
+188,678
+29% +$956K ﹤0.01% 4792
2025
Q1
$4.32M Buy
647,830
+77,867
+14% +$769K ﹤0.01% 3934
2024
Q4
$7.16M Buy
569,963
+231,829
+69% +$3.49M ﹤0.01% 3427
2024
Q3
$6.25M Sell
338,134
-67,648
-17% -$1.39M ﹤0.01% 2835
2024
Q2
$8.74M Sell
405,782
-103,172
-20% -$2.37M ﹤0.01% 2328
2024
Q1
$13.7M Buy
508,954
+466,150
+1,089% +$13.2M ﹤0.01% 2005
2023
Q4
$1.28M Sell
42,804
-215,425
-83% -$4.75M ﹤0.01% 4275
2023
Q3
$5.29M Buy
258,229
+230,812
+842% +$4.2M ﹤0.01% 2513
2023
Q2
$545K Sell
27,417
-88,737
-76% -$1.79M ﹤0.01% 4746
2023
Q1
$1.99M Sell
116,154
-179,107
-61% -$3.51M ﹤0.01% 3434
2022
Q4
$5.78M Buy
295,261
+198,358
+205% +$3.65M ﹤0.01% 2358
2022
Q3
$1.55M Buy
96,903
+30,116
+45% +$470K ﹤0.01% 3385
2022
Q2
$919K Sell
66,787
-107,410
-62% -$1.28M ﹤0.01% 3807
2022
Q1
$2.76M Buy
174,197
+33,465
+24% +$578K ﹤0.01% 3122
2021
Q4
$3.07M Buy
140,732
+44,829
+47% +$1.22M ﹤0.01% 3331
2021
Q3
$2.87M Buy
95,903
+83,742
+689% +$3.05M ﹤0.01% 3246
2021
Q2
$539K Sell
12,161
-62,052
-84% -$2.69M ﹤0.01% 4669
2021
Q1
$3.29M Buy
74,213
+28,048
+61% +$1.54M ﹤0.01% 3032
2020
Q4
$2.53M Buy
46,165
+25,991
+129% +$947K ﹤0.01% 3175
2020
Q3
$461K Buy
20,174
+17,126
+562% +$422K ﹤0.01% 4259
2020
Q2
$64K Sell
3,048
-27,360
-90% -$493K ﹤0.01% 5667
2020
Q1
$425K Sell
30,408
-25,706
-46% -$509K ﹤0.01% 4114
2019
Q4
$1.28M Buy
56,114
+3,763
+7% +$62.8K ﹤0.01% 3978
2019
Q3
$610K Buy
52,351
+46,779
+840% +$581K ﹤0.01% 4386
2019
Q2
$84K Buy
5,572
+5,562
+55,620% +$97.1K ﹤0.01% 5504
2019
Q1
$0 Sell
10
-18,014
-100% -$284K ﹤0.01% 8080
2018
Q4
$267K Buy
18,024
+13,009
+259% +$216K ﹤0.01% 4729
2018
Q3
$123K Buy
5,015
+1,376
+38% +$29.8K ﹤0.01% 5410
2018
Q2
$71K Buy
3,639
+2,061
+131% +$39K ﹤0.01% 5710
2018
Q1
$29K Buy
+1,578
New +$25.7K ﹤0.01% 6118
2017
Q3
Sell
-47
Closed 7938
2017
Q2
$0 Sell
47
-89
-65% -$664 ﹤0.01% 7922
2017
Q1
$1K Sell
136
-560
-80% -$3.77K ﹤0.01% 7450
2016
Q4
$17K Buy
696
+347
+99% +$9.9K ﹤0.01% 6615
2016
Q3
$13K Buy
+349
New +$11K ﹤0.01% 6606
2016
Q2
Sell
-9,656
Closed -$286K 7927
2016
Q1
$286K Buy
9,656
+9,630
+37,038% +$289K ﹤0.01% 4221
2015
Q4
$1K Sell
26
-1,336
-98% -$58.2K ﹤0.01% 8169
2015
Q3
$51K Sell
1,362
-234
-15% -$10.7K ﹤0.01% 5812
2015
Q2
$31K Buy
1,596
+1,359
+573% +$30.1K ﹤0.01% 6452
2015
Q1
$5K Buy
+237
New +$5.56K ﹤0.01% 8117

Other funds holding RCKT